215 related items for PubMed ID: 2821447
1. Long term results of transsphenoidal adenomectomy in patients with Cushing's disease.
Nakane T, Kuwayama A, Watanabe M, Takahashi T, Kato T, Ichihara K, Kageyama N.
Neurosurgery; 1987 Aug; 21(2):218-22. PubMed ID: 2821447
[Abstract] [Full Text] [Related]
2. Repeat transsphenoidal surgery for Cushing's disease.
Friedman RB, Oldfield EH, Nieman LK, Chrousos GP, Doppman JL, Cutler GB, Loriaux DL.
J Neurosurg; 1989 Oct; 71(4):520-7. PubMed ID: 2552045
[Abstract] [Full Text] [Related]
3. Transsphenoidal surgery for Cushing's disease: endocrinological follow-up monitoring of 82 patients.
Shimon I, Ram Z, Cohen ZR, Hadani M.
Neurosurgery; 2002 Jul; 51(1):57-61; discussion 61-2. PubMed ID: 12182435
[Abstract] [Full Text] [Related]
4. Transnasal microsurgery in children and adolescents with Cushing's disease.
Knappe UJ, Lüdecke DK.
Neurosurgery; 1996 Sep; 39(3):484-92; discussion 492-3. PubMed ID: 8875478
[Abstract] [Full Text] [Related]
5. Long-term follow-up results of transsphenoidal surgery for Cushing's disease in a single centre using strict criteria for remission.
Rees DA, Hanna FW, Davies JS, Mills RG, Vafidis J, Scanlon MF.
Clin Endocrinol (Oxf); 2002 Apr; 56(4):541-51. PubMed ID: 11966748
[Abstract] [Full Text] [Related]
6. Intracavernous sinus ectopic adrenocorticotropin-secreting tumours causing therapeutic failure in transsphenoidal surgery for Cushing's disease.
Ohnishi T, Arita N, Yoshimine T, Mori S.
Acta Neurochir (Wien); 2000 Apr; 142(8):855-64. PubMed ID: 11086823
[Abstract] [Full Text] [Related]
7. Postoperative plasma cortisol levels predict long-term outcome in patients with Cushing's disease and determine which patients should be treated with pituitary irradiation after surgery.
Imaki T, Tsushima T, Hizuka N, Odagiri E, Murata Y, Suda T, Takano K.
Endocr J; 2001 Feb; 48(1):53-62. PubMed ID: 11403103
[Abstract] [Full Text] [Related]
8. A critical evaluation of transsphenoidal pituitary surgery in the treatment of Cushing's disease: prediction of outcome.
Arnott RD, Pestell RG, McKelvie PA, Henderson JK, McNeill PM, Alford FP.
Acta Endocrinol (Copenh); 1990 Oct; 123(4):423-30. PubMed ID: 2173325
[Abstract] [Full Text] [Related]
9. Transsphenoidal resection in Cushing's disease: undetectable serum cortisol as the definition of successful treatment.
Trainer PJ, Lawrie HS, Verhelst J, Howlett TA, Lowe DG, Grossman AB, Savage MO, Afshar F, Besser GM.
Clin Endocrinol (Oxf); 1993 Jan; 38(1):73-8. PubMed ID: 8435888
[Abstract] [Full Text] [Related]
10. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
Mukherjee A, Murray RD, Teasdale GM, Shalet SM.
Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
[Abstract] [Full Text] [Related]
11. Transsphenoidal surgery for Cushing's disease.
Fahlbusch R, Buchfelder M, Müller OA.
J R Soc Med; 1986 May; 79(5):262-9. PubMed ID: 3014145
[Abstract] [Full Text] [Related]
12. Transsphenoidal adenomectomy in Cushing's disease via a lateral rhinotomy approach.
Petruson K, Jakobsson KE, Petruson B, Lindstedt G, Bengtsson BA.
Surg Neurol; 1997 Jul; 48(1):37-43; discussion 44-5. PubMed ID: 9199682
[Abstract] [Full Text] [Related]
13. Transsphenoidal surgery for Cushing's disease: outcome in patients with a normal magnetic resonance imaging scan.
Semple PL, Vance ML, Findling J, Laws ER.
Neurosurgery; 2000 Mar; 46(3):553-8; discussion 558-9. PubMed ID: 10719850
[Abstract] [Full Text] [Related]
14. Cushing's disease: results of transsphenoidal microsurgery with emphasis on surgical failures.
Tindall GT, Herring CJ, Clark RV, Adams DA, Watts NB.
J Neurosurg; 1990 Mar; 72(3):363-9. PubMed ID: 2303869
[Abstract] [Full Text] [Related]
15. Intra- and postoperative plasma ACTH concentrations in patients with Cushing's disease cured by transsphenoidal pituitary surgery.
Czirják S, Bezzegh A, Gál A, Rácz K.
Acta Neurochir (Wien); 2002 Oct; 144(10):971-7; discussion 977. PubMed ID: 12382124
[Abstract] [Full Text] [Related]
16. Corticotropin-releasing hormone stimulation test before and after transsphenoidal selective microadenomectomy in 30 patients with Cushing's disease.
Schrell U, Fahlbusch R, Buchfelder M, Riedl S, Stalla GK, Müller OA.
J Clin Endocrinol Metab; 1987 Jun; 64(6):1150-9. PubMed ID: 3033006
[Abstract] [Full Text] [Related]
17. Apparently complete restoration of normal daily adrenocorticotropin, cortisol, growth hormone, and prolactin secretory dynamics in adults with Cushing's disease after clinically successful transsphenoidal adenomectomy.
Veldman RG, Frölich M, Pincus SM, Veldhuis JD, Roelfsema F.
J Clin Endocrinol Metab; 2000 Nov; 85(11):4039-46. PubMed ID: 11095430
[Abstract] [Full Text] [Related]
18. Anterior pituitary function after transsphenoidal selective adenomectomy in patients with Cushing's disease.
Kuwayama A, Kageyama N, Nakane T, Watanabe M, Kanie N.
J Clin Endocrinol Metab; 1981 Jul; 53(1):165-73. PubMed ID: 6263935
[Abstract] [Full Text] [Related]
19. Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance.
Atkinson AB, Kennedy A, Wiggam MI, McCance DR, Sheridan B.
Clin Endocrinol (Oxf); 2005 Nov; 63(5):549-59. PubMed ID: 16268808
[Abstract] [Full Text] [Related]
20. Transsphenoidal microsurgery for Cushing's disease: initial outcome and long-term results.
Hammer GD, Tyrrell JB, Lamborn KR, Applebury CB, Hannegan ET, Bell S, Rahl R, Lu A, Wilson CB.
J Clin Endocrinol Metab; 2004 Dec; 89(12):6348-57. PubMed ID: 15579802
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
